SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001104659-24-031990
Filing Date
2024-03-07
Accepted
2024-03-07 18:27:45
Documents
5
Effectiveness Date
2024-03-07

Document Format Files

Seq Description Document Type Size
1 S-1MEF tm245173d10_s1mef.htm S-1MEF 32715
2 EXHIBIT 5.1 tm245173d10_ex5-1.htm EX-5.1 7809
3 EXHIBIT 23.1 tm245173d10_ex23-1.htm EX-23.1 2372
4 EX-FILING FEES tm245173d10_ex-filingfees.htm EX-FILING FEES 12363
5 GRAPHIC tm245173d10_ex5-1img001.jpg GRAPHIC 2175
  Complete submission text file 0001104659-24-031990.txt   59655
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-277763 | Film No.: 24731801
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)